Cureus Ocular Complications in Patients on Highly Active

Our article aims to report the ocular adverse effects of highly active antiretroviral therapy (HAART). In case 1, a 26-year-old male patient presented with a diminution of vision. In the absence of active cytomegalovirus (CMV) retinitis and a surge in CD4 count of more than 100 cells/µL over four months, he was diagnosed as a case of immune recovery uveitis (IRU). He responded well to topical steroids and cycloplegics. In case 2, while dry eye is a common adverse effect of HAART, our 53-year-old female patient progressed to a visually distressing stage of keratoconjunctivitis sicca. She responded to lubricants and continues to be on the same. In case 3, a 14-year-old female patient’s vision succumbed to Stevens-Johnson syndrome due to nevirapine in the absence of timely intervention. Though uncommon, debilitating ocular adverse effects may be seen with HAART. Further studies and reporting are required for an increased awareness among physicians and patients.

Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist - ScienceDirect

Neurologic complications of coronavirus infections

Frontiers Case Report: Anterior Scleritis Presenting as a Primary Ocular Manifestation in Multisystem Inflammatory Syndrome in Children With COVID-19

What Do We See When Our Eyes Are Closed? - WSJ

Bradycardia, headache, and vomiting in a child after a fall

Oxygen-Generating Cyanobacteria Powered by Upconversion-Nanoparticles-Converted Near-Infrared Light for Ischemic Stroke Treatment

Fierce Healthcare's 2022 Women of Influence Awards

Ocular Manifestations of Systemic Diseases

Ocular complications of uveitis (±steroid treatment).

Eye drop recall stirs concern about over-the-counter drug safety

CRSToday Common Postoperative Complications

Frontiers A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences